Assignee
DYNOGEN PHARMACEUTICALS INC
US·9 granted patents·28 pending applications·132 citations·filing 2003–2009
Top patents by PatentIndex Score
37 records- 0195US7041704B2Methods of treating gastrointestinal tract disorders using sodium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2005·Granted May 9, 2006·34 cites·9 claims
- 0291US6846823B2Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2005·50 cites·62 claims
- 0383US7459430B2Methods of using ziconotide to treat overactive bladderDYNOGEN PHARMACEUTICALS INC·Filed 2006·Granted Dec 2, 2008·2 cites·14 claims
- 0483US7084116B2Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Aug 1, 2006·13 cites·14 claims
- 0580US7125848B2Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Oct 24, 2006·9 cites·14 claims
- 0679US7115606B2Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Oct 3, 2006·11 cites·16 claims
- 0778US7094786B2Method of treating nausea, vomiting, retching or any combination thereofDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Aug 22, 2006·12 cites·3 claims
- 0869US2008269276A1Compositions useful for treating irritable bowel syndromeDYNOGEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0968US7223754B2Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted May 29, 2007·1 cites·16 claims
- 1066US2009203792A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1163US2007066597A1Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disordersDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1261US2005107353A1Methods of treating lower urinary tract disorders using losigamoneDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1360US2009131471A1Compositions useful for treating gastroesophageal reflux diseaseDYNOGEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1460US2008085916A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1559US7470690B24-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorderDYNOGEN PHARMACEUTICALS INC·Filed 2003·Granted Dec 30, 2008·0 cites·3 claims
- 1659US2004209960A1Methods of treating lower urinary tract disorders using sodium channell modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1758US2004213842A1Methods of treating gastrointestinal tract disorders using sodium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1858US2006188575A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1958US2005054725A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2058US2009215791A1New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidineDYNOGEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2157US2005192270A1Methods of decreasing intestinal motilityDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2257US2007060652A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2357US2004147509A1Method of treating functional bowel disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2456US2005228049A1Methods for decreasing detrusorDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2556US2004142034A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2656US2006247311A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2755US2005113421A1Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2855US2005059704A1Compositions useful for treating gastrointestinal motility disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2955US2007010543A1Compositions and methods for treating gastrointestinal hypomotility and associated disordersDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3054US2005239890A1Methods for decreasing detrusor muscle overactivityDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3154US2004192730A1Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunctionDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3254US2004248979A1Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3351US2007105785A1Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3449US2004147510A1Method of treating nausea, vomiting, retching or any combination thereofDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3548US2007254899A1Soluble salts of thieno[2,3-d]pyrimidine derivativesDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3644US2006293309A1Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3744US2007254891A1Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidineDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DYNOGEN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →